Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial lipopolysaccharide (LPS) O-antigens are the highly variable, outermost polysaccharide components of the LPS molecule found in the outer membrane of Gram-negative bacteria. They consist of repeating oligosaccharide units that extend from the bacterial surface, serving as a critical interface between the pathogen and the host environment. O-antigens play a vital role in bacterial pathogenesis by providing a physical barrier against host immune defenses, such as complement-mediated lysis and phagocytosis, and by facilitating motility and biofilm formation. Due to their high immunogenicity and surface exposure, O-antigens are primary targets for the development of serotype-specific vaccines and monoclonal antibodies. However, their extreme structural diversity across different bacterial strains and species presents a significant challenge for broad-spectrum therapeutic development, often necessitating multivalent or strain-specific approaches.
Drugs targeting O-antigens primarily work through neutralization of bacterial attachment, opsonization to enhance phagocytosis, and activation of the classical complement pathway to mediate bacterial killing. Vaccines induce the production of serotype-specific antibodies that bind to the O-antigen, preventing colonization and promoting immune clearance of the pathogen.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial lipopolysaccharide O-antigen (O-antigen).